Objective： To investigate the cell cycle changes of hepatoma cells and the role of antisense oligonucleotide targeting bFGF. Methods： Inhibition of bFGF protein expression was investigated by confocal microscopy ana...Objective： To investigate the cell cycle changes of hepatoma cells and the role of antisense oligonucleotide targeting bFGF. Methods： Inhibition of bFGF protein expression was investigated by confocal microscopy analysis and Western blot in the best condition of transfecting antisense oligonucleotide targeting bFGF. Cell cycle and apoptosis were detected with flow cytometry analysis. Results： Treatment with antisense oligonucleotide of bFGF not only reduced the expression of bFGF by confocal microscopy and Western blot analysises, but also increased the apoptosis of HepG2 cells （ P 〈 0.01）. Conclusion： bFGF may take part in apoptosis regulation of hepatoma cells and be used as a target of hepatocellular carcinoma therapy.展开更多
文摘Objective： To investigate the cell cycle changes of hepatoma cells and the role of antisense oligonucleotide targeting bFGF. Methods： Inhibition of bFGF protein expression was investigated by confocal microscopy analysis and Western blot in the best condition of transfecting antisense oligonucleotide targeting bFGF. Cell cycle and apoptosis were detected with flow cytometry analysis. Results： Treatment with antisense oligonucleotide of bFGF not only reduced the expression of bFGF by confocal microscopy and Western blot analysises, but also increased the apoptosis of HepG2 cells （ P 〈 0.01）. Conclusion： bFGF may take part in apoptosis regulation of hepatoma cells and be used as a target of hepatocellular carcinoma therapy.
